Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 3/20 | 0.35 |
| ▸ | GLB1 | P16278 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3016094 | 0.86 | ALDH1A1 (0.41) | ALDH1A1KDM4EHTTMAPTNPSR1 | |
| SCHEMBL3123162 | 0.85 | ALDH1A1 (0.41) | ALDH1A1KDM4EHTTNPSR1BRCA1 | |
| SCHEMBL3693210 | 0.82 | CHRM2 (0.39) | ALDH1A1KDM4EMEN1KMT2ATP53 | |
| SCHEMBL3019641 | 0.79 | NPC1 (0.44) | ALDH1A1KDM4EMEN1KMT2ATP53 | |
| SCHEMBL3020892 | 0.77 | LMNA (0.40) | ALDH1A1KDM4EMEN1KMT2ATP53 | |
| SCHEMBL3004679 | 0.77 | ALDH1A1 (0.35) | ALDH1A1KDM4EHTTBRCA1FUCA1 | |
| SCHEMBL3022329 | 0.76 | CHRM3 (0.37) | KDM4EMEN1KMT2ATP53MAPT | |
| SCHEMBL862555 | 0.75 | CYP1A2 (0.44) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| SCHEMBL842177 | 0.74 | ALDH1A1 (0.41) | ALDH1A1KDM4EMEN1KMT2ATP53 | |
| SCHEMBL13214427 | 0.73 | ALDH1A1 (0.45) | ALDH1A1KDM4EHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2195310-B1 | LUMINESCENT LANTHANIDE (III) CHELATES, CHELATING AGENTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2016-06-01 | — | — | EP | disclosed |
| US-8221719-B2 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | WALLAC OY (FI) | 2012-07-17 | — | — | US | disclosed |
| US-20100204442-A1 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | WALLAC OY (FI) | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204442-A1 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof | LNPEP, SLC39A3, LAP3 | ALDH1A1 4545/4885KDM4E 2737/4885HTT 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.